Mean ± SD, or n (%) | |||
---|---|---|---|
Patients with vascular events (n = 41) | Patients without vascular events (n = 109) | P value | |
Baseline clinical characteristics | |||
Age, years | 64.9 ± 10.4 | 60.6 ± 12.2 | 0.047 |
Sex, male | 28 (68.3) | 81 (74.3) | 0.461 |
BMI, kg/m2 | 25.6 ± 3.3 | 25.5 ± 3.4 | 0.868 |
History of smoking | 24 (58.5) | 67 (61.5) | 0.743 |
History of hypertension | 28 (68.3) | 79 (72.5) | 0.614 |
History of diabetes | 7 (17.1) | 35 (32.1) | 0.068 |
History of hyperlipidemia | 16 (39.0) | 59 (54.1) | 0.099 |
History of coronary heart disease | 5 (12.2) | 12 (11.0) | 0.839 |
History of stroke | 20 (48.8) | 38 (34.9) | 0.119 |
Systolic blood pressure, mm Hg | 147.6 ± 23.2 | 144.7 ± 24.0 | 0.223 |
Diastolic blood pressure, mm Hg | 88.6 ± 13.5 | 86.6 ± 16.2 | 0.236 |
HDL, mmol/L | 1.1 ± 0.3 | 1.2 ± 0.6 | 0.374 |
LDL, mmol/L | 2.5 ± 1.4 | 2.9 ± 1.4 | 0.096 |
Total cholesterol, mmol/L | 4.2 ± 1.3 | 4.4 ± 1.2 | 0.398 |
Triglycerides, mmol/L | 1.7 ± 1.4 | 1.7 ± 1.0 | 0.646 |
NIHSS score | 5.6 ± 4.3 | 3.3 ± 3.0 | 0.003 |
Drug treatment during follow-up | |||
Antihypertension | 17 (41.5) | 49 (45.0) | 1.000 |
Lipid-lowering | 33 (80.5) | 86 (78.9) | 0.203 |
Anticoagulation | 22 (53.7) | 63 (57.8) | 0.064 |
Antiplatelet | 21 (51.2) | 39 (35.8) | 0.368 |